CytoDyn (CYDY) Shares Outstanding (Entity) (2010 - 2026)
Powered by 
Analysis
CytoDyn (CYDY) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | 253.35 Mn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn | 399.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | 214.24 Mn |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 113.02 Mn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 133.73 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | 575.00 Mn |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 218.28 Mn |
| 10 | CytoDyn | 257.86 Mn | 257.86 Mn | - | 1.37 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 1.37 Bn |
| Feb 28, 2026 | 1.36 Bn |
| Nov 30, 2025 | 1.27 Bn |
| Aug 31, 2025 | 1.26 Bn |
| May 31, 2025 | 1.25 Bn |
| Feb 28, 2025 | 1.23 Bn |
| Nov 30, 2024 | 1.22 Bn |
| Aug 31, 2024 | 1.22 Bn |
| May 31, 2024 | 1.06 Bn |
| Feb 29, 2024 | 989.93 Mn |
| Nov 30, 2023 | 971.29 Mn |
| Aug 31, 2023 | 930.96 Mn |
| May 31, 2023 | 918.61 Mn |
| Feb 28, 2023 | 836.59 Mn |
| Nov 30, 2022 | 824.84 Mn |
| Aug 31, 2022 | 812.26 Mn |
| May 31, 2022 | 719.59 Mn |
| Feb 28, 2022 | 713.29 Mn |
| Nov 30, 2021 | 685.42 Mn |
| Aug 31, 2021 | 643.68 Mn |